Companies: 10,795·Total market cap: $144.5T
Health Sciences Acquisitions Corporation 2

Health Sciences Acquisitions Corporation 2

HSAQNASDAQFinancial Services
$13.31
+$2.59(+24.16%)
Market Cap$149233051
P/E Ratio
52W High$13.8
52W Low$9.41
Overview

Health Sciences Acquisitions Corporation 2(HSAQ)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HSAQ · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122022-122021-122020-12
Revenue
Revenue$33.48M$2.64M$0.00M$0.00M$0.00M
Cost of Revenue$0.19M$0.20M$0.00M$0.00M$0.00M
Gross Profit$33.29M$2.43M$0.00M$0.00M$0.00M
Gross Margin %(computed)99.43%92.27%
Operating Expenses
R&D Expenses$58.19M$42.80M$0.00M$0.00M$0.00M
G&A Expenses$0.00M$0.00M$2.96M$0.27M$0.13M
Total Operating Expenses$85.10M$66.73M$2.96M$0.27M$0.18M
Operating Income($51.81M)($64.30M)($3.08M)($0.39M)($0.17M)
Operating Margin %(computed)-154.73%
Interest Income$0.00M$0.00M$0.35M$0.02M$0.00M
Interest Expense($1.15M)$0.00M($0.35M)($0.02M)$0.00M
Income Before Tax($52.95M)($61.02M)($2.74M)($0.38M)($0.17M)
Income Tax Expense$0.00M$0.00M($0.35M)($0.02M)$0.00M
Net Income($52.95M)($61.02M)($2.39M)($0.36M)($0.17M)
Net Margin %(computed)-158.16%
Per Share & EBITDA
EPS (Basic)$-1.11$-1.66$-0.15$-0.02$-0.01
Wtd Avg Shares38392.72M36821.04M16.43M20.27M20.27M
EBITDA($51.81M)($64.30M)($2.74M)($0.38M)($0.17M)
EBITDA Margin %(computed)-154.73%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Health Sciences Acquisitions Corporation 2

关于Health Sciences Acquisitions Corporation 2(HSAQ)损益表

Health Sciences Acquisitions Corporation 2(HSAQ)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,HSAQ实现营收$0.03B,毛利润$0.03B(毛利率99.43%),净利润($0.05B)(净利率-158.16%)。

常见问题

HSAQ · 4 问

Health Sciences Acquisitions Corporation 2(HSAQ)2025财年营收为$0.03B,同比up1169.2%。

HSAQ revenueHSAQ salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09